Promoted Companies
SORT BY:
Viral Genetics Inc. (VRAL)
| Total paid for Promotions this month: | $85,000 | ||
| E-mails this Month: | 2 | ||
| Estimated Volume Generated: | $269,733 | ||
| Research Report on VRAL: | Click to see | ||
| * The information presented is based on information for May , 2012 | |||
Monster News from VRAL After Yesterday's Close, Could be a DOUBLE... May 22, 2012 09:32
My new Biotech Blastoff Alert is VRAL - Viral Genetics
About VRAL Viral Genetics, Inc., a biotechnology company, discovers and develops immune-based therapies for the treatment of HIV/AIDS and other infectious, autoimmune, and immunological deficiency disorders. It develops its products using its thymus nuclear protein compound. The company’s product includes VGV-X for the treatment of HIV infection and AIDS. It also develops VGV-L for Lyme
...read more
| Promoter: | Darth Trader | Paying Party: | Lake Group Media, Inc. |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VRAL | $85,000 | 269,733 |
| Max Profit: 23.75 % | Gain at close: -25.00 % |
*** VRAL is my 1 Cent Biotech 1 in a Billion News Alert! *** May 22, 2012 09:32
My new Biotech Blastoff Alert is VRAL - Viral Genetics
About VRAL Viral Genetics, Inc., a biotechnology company, discovers and develops immune-based therapies for the treatment of HIV/AIDS and other infectious, autoimmune, and immunological deficiency disorders. It develops its products using its thymus nuclear protein compound. The company’s product includes VGV-X for the treatment of HIV infection and AIDS. It also develops VGV-L for Lyme
...read more
| Promoter: | The Stock Psycho | Paying Party: | Lake Group Media, Inc. |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VRAL | $85,000 | 269,733 |
| Max Profit: 23.75 % | Gain at close: -25.00 % |
Turn your attention to VRAL May 22, 2012 07:14
Viral Genetics’ P-IND Clears FDA To Commence Clinical Trials in Humans
Set to Begin First Ovarian Cancer Study Test Site for Metabolic Disruption Technology (MDT) Combination Therapy
A physician-initiated Investigational New Drug (P-IND) application submitted to the FDA in late April, 2012, has cleared the FDA’s screening process with the requirement for a regular IND application being
...read more
| Promoter: | The Bull Report | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VRAL | $15,000 | UNKNOWN |
| Max Profit: 7.39 % | Gain at close: Pending |
News is out on VRAL Mar 07, 2012 08:56
News is out on VRAL and Research 2.0 just put out a full report Recent news Viral Genetics Submits Pre-IND Document for Lyme Disease Drug Candidate to FDA http://finance.yahoo.com/news/viral-genetics-submits-pre-ind-133000625.html Research 2.0 New report on VRAL http://www.viralgenetics.com/investors/press-releases/VRAL_REPORT_03062012.pdf
BarCharts has a HOLD Rating on VRAL!
http://www.barchart.com/quotes/stocks/VRAL
Viral
...read more
| Promoter: | The Bull Report | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VRAL | $15,000 | UNKNOWN |
| Max Profit: 7.39 % | Gain at close: Pending |
VRAL News Alert..... Feb 02, 2012 11:16
News Alert on VRAL:
SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011
...read more
| Promoter: | SmartPennyInvest.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VRAL | $2,500 | 29,248 |
| Max Profit: 27.39 % | Gain at close: -10.83 % |
VRAL News Alert..... Feb 02, 2012 11:10
News Alert on VRAL:
SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011
...read more
| Promoter: | JumpingPennyStocks.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VRAL | $2,500 | 29,248 |
| Max Profit: 27.39 % | Gain at close: -10.83 % |
VRAL News Alert..... Feb 02, 2012 11:09
News Alert on VRAL:
SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011
...read more
| Promoter: | HotOTCBuzz.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VRAL | $2,500 | 29,248 |
| Max Profit: 27.39 % | Gain at close: -10.83 % |
VRAL News Alert..... Feb 02, 2012 10:51
News Alert on VRAL:
SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011
...read more
| Promoter: | HotPennyInvest.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VRAL | $2,500 | 29,248 |
| Max Profit: 27.39 % | Gain at close: -10.83 % |
VRAL News Alert..... Feb 02, 2012 10:49
News Alert on VRAL:
SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011
...read more
| Promoter: | HotOTCChina.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VRAL | $2,500 | 29,248 |
| Max Profit: 27.39 % | Gain at close: -10.83 % |
VRAL News Alert..... Feb 02, 2012 10:45
News Alert on VRAL:
SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing programs, are below. In particular, in 2011
...read more
| Promoter: | OTCReporter | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| VRAL | $2,500 | 29,248 |
| Max Profit: 27.39 % | Gain at close: -10.83 % |